Platelet Rich Plasma Market, By Type (Pure Platelet-rich Plasma, Leukocyte-rich Platelet-rich Plasma, and Pure Platelet-rich Fibrin), By Origin (Autologous Platelet-rich Plasma, Allogeneic Platelet-rich Plasma, and Homologous Platelet-rich Plasma), By Application (Orthopedic Surgery, Neurosurgery, Cosmetic Surgery, and General Surgery), By End User (Hospitals & Clinics, and Research Institutes) and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Report Code: PMI127419 | Publish Date: March 2024 | No. of Pages: 180

Global Platelet Rich Plasma Market Overview

Introduction:

Platelet Rich Plasma Market was valued at US$ 410.7 million in 2024 and is projected to grow at a CAGR of 9.6 % to reach US$ 945.2 million by 2034.

Platelet-rich plasma (PRP) has atleast seven growth factors. It can be used to treat chronic tendon injuries, acute ligament and muscle injuries, surgery, knee arthritis, fractures, and discomfort, among other conditions. The usage of PRP in orthopaedics is predicted to rise over the projection period. Acute sports injuries, such as muscular strains, are increasingly being treated using PRP. PRP is becoming more popular, however its true usefulness has yet to be determined. As a result, PRP is frequently utilised in surgery to repair injured knee ligaments like the anterior cruciate ligament (ACL). PRP aids in the rapid healing of tissue following surgical treatments. Several research studies are under underway to determine the efficacy of PRP in different therapy areas, such as herniated discs and hair loss. Because of its increased availability and capacity to speed up recovery, PRP is now frequently used in a variety of therapeutic fields. Additionally, this treatment has the potential to cut the financial expenditures of typical medical treatments, while it cannot completely replace many vital traditional therapies. 

Impact of Covid-19 pandemic on market

Stakeholders in the platelet rich plasma market are paying attention to research papers from Indonesia. Because of the rising number of COVID-19 cases in Indonesia, autologous activated platelet-rich plasma (aaPRP) is gaining popularity as a treatment for cytokine release syndrome (CRS). Because cytokine storm is a common symptom among coronavirus patients in Indonesia, intravenous autologous activated platelet-rich plasma has the potential to lower mortality rates. During the ongoing pandemic, medical treatments have been postponed or rescheduled, affecting revenue flow in the platelet rich plasma business. Nonetheless, firms are performing extensive vendor reviews to ensure that healthcare institutions have reliable medical supplies. They are looking into how to keep track of expiration dates and replace old supplies with new ones.

Platelet Rich Plasma Market - Introduction

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Global Platelet Rich Plasma Market Dynamics

Plasma therapy manufacturers are investing extensively in R&D

The number of clinical trials involving the use of plasma-rich proteins in the treatment of the coronavirus has increased dramatically in recent months, according to the US Food and Drug Administration. Various plasma therapy manufacturers are investing extensively in R&D and clinical studies in the hopes of developing an antiviral to combat the coronavirus. For instance, Arthritis is the greatest cause of disability among people, according to a report published in the Lancet Journal in 2020. Furthermore, among all osteoarthritis, knee osteoarthritis has a significant prevalence. Knee OA will affect roughly 654 million persons worldwide by 2020. (age 40 and up). People aged 20 and up were shown to have a higher prevalence of knee osteoarthritis.

Despite the fact that PRP injections are not considered conventional practise, an increasing number of patients are opting for them to treat a growing array of orthopaedic diseases, including osteoarthritis. It is most typically used to treat knee osteoarthritis, although it can also be used to treat other joints. When a clinician uses platelet-rich plasma to treat osteoarthritis, he or she injects PRP directly into the afflicted joint to relieve pain, enhance joint function, and slow, stop, or even heal cartilage deterioration. Platelet-rich plasma is obtained from a sample of the patient's blood in such instances.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Platelet Rich Plasma Market Segmentation

The platelet rich plasma market report segments the market on the basis of type, origin, application, end user and region.

On the basis of Type, the global platelet rich plasma market is segmented into Pure Platelet-rich Plasma, Leukocyte-rich Platelet-rich Plasma, and Pure Platelet-rich Fibrin. On the basis of Origin, the target market is segmented into Autologous Platelet-rich Plasma, Allogeneic Platelet-rich Plasma, and Homologous Platelet-rich Plasma. Based on Application the market is segmented into Orthopedic Surgery, Neurosurgery, Cosmetic Surgery, and General Surgery. Based on End User the market is segmented into Hospitals & Clinics, and Research Institute.

Regional Insights:

Platelet Rich Plasma Market - Region Insights

On region the platelet rich plasma market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The rise in the prevalence of numerous ailments, such as arthritis, well-established healthcare infrastructure, improved regulatory environment, and government assistance are all contributing to market expansion in the United States. According to a poll done by the Centers for Condition Control and Prevention (CDC) in 2020, one out of every four persons in the United States had arthritis, with a projected 78 million adults suffering from the disease by 2040. Furthermore, the prevalence of doctor-diagnosed arthritis is predicted to climb dramatically in the region over the forecast period, owing to the region's ageing population. Osteoarthritis is the most common kind of arthritis, affecting around 31 million Americans each year.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Market Size 2024

US$ 410.7 million

Projected Market Size 2034

US$ 945.2 million

CAGR Growth Rate

9.6%

Base year for estimation

2023

Forecast period

2024 – 2034

Market representation

Revenue in USD Million & CAGR from 2024 to 2034

Market Segmentation

By Type - Pure Platelet-rich Plasma, Leukocyte-rich Platelet-rich Plasma, and Pure Platelet-rich Fibrin

By Origin – Autologous Platelet-rich Plasma, Allogeneic Platelet-rich Plasma, and Homologous Platelet-rich Plasma

By Application – Orthopedic Surgery, Neurosurgery, Cosmetic Surgery, and General Surgery

By End User – Hospitals & Clinics, and Research Institute

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the global platelet rich plasma market report based on Type, Origin, Application, End User and Region.

Platelet Rich Plasma Market - Detailed Segmentation

Global Oncology Drug Market, By Region:

  • North America
    • U.S.
      • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Platelet Rich Plasma Market Key Players

The key players operating in the platelet rich plasma market includes Harvest Technologies Corp., Arthrex, Inc., Zimmer Biomet Holdings, Inc., EmCyte Corporation, Regen Lab SA, Exactech, Inc., Cesca Therapeutics, Inc., Nuo Therapeutics, Inc., DePuy Synthes (Johnson & Johnson) and ISTO Biologics

Global Platelet Rich Plasma Market Company Profile

  • Harvest Technologies Corp.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Arthrex, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Zimmer Biomet Holdings, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • EmCyte Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Regen Lab SA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Exactech, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cesca Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Nuo Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • DePuy Synthes (Johnson & Johnson)
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • ISTO Biologics
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

 “*” marked represents similar segmentation in other categories in the respective section

Global Platelet Rich Plasma Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for Oncology Drug Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Type
      • Market Snippet, By Origin
      • Market Snippet, By Application
      • Market Snippet, By End-User
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Market Segmentation, By Type, 2020 – 2030, (US$ Mn)
    • Overview                     
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Pure Platelet-Rich Plasma
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Leukocyte-Rich Plasma
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Pure Platelet-Rich Fibrin
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Market Segmentation, By Origin, 2020 – 2030, (US$ Mn)
    • Overview                                      
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Autologous Platelet-Rich Plasma
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Allogeneic Platelet-Rich Plasma
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Homologous Platelet Rich-Plasma
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Market Segmentation, By Application, 2020 – 2030, (US$ Mn)
    • Overview                                      
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Orthopedic Surgery
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Neurosurgery
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Cosmetic Surgery
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • General Surgery
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  8. Market Segmentation, By End-User, 2020 – 2030, (US$ Mn)
    • Overview                                               
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hospital & Clinics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Research Institutes
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  9. Global Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Origin, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Origin, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Origin, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Origin, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Origin, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  10. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  11. Company Profiles

 

  • Harvest Technologies Corp.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Arthrex, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Zimmer Biomet Holdings, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • EmCyte Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Regen Lab SA
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Exactech, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Cesca Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Nuo Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • DePuy Synthes (Johnson & Johnson)
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • ISTO Biologics
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

Platelet rich plasma market is segmented based on Type, Origin, Application, and End User & Region.

Various plasma therapy manufacturers are investing extensively in R&D and clinical studies in the hopes of developing an antiviral to combat the coronavirus.

The rise in the prevalence of numerous ailments, such as arthritis, well-established healthcare infrastructure, improved regulatory environment, and government assistance are all contributing to market expansion in the United States.

The key players operating in platelet rich plasma market includes Harvest Technologies Corp., Arthrex, Inc., Zimmer Biomet Holdings, Inc., EmCyte Corporation, Regen Lab SA, Exactech, Inc., Cesca Therapeutics, Inc., Nuo Therapeutics, Inc., DePuy Synthes (Johnson & Johnson) and ISTO Biologics